Growth Metrics

Carlsmed (CARL) Current Leases (2024 - 2026)

Carlsmed posted quarterly Current Leases of $776000.0 for Q1 2026, up 3.19% on a QoQ basis from $752000.0 in Q4 2025.

Carlsmed (CARL) has 3 years of Current Leases data on file, last reported at $776000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases changed N/A year-over-year to $776000.0; the trailing twelve-month figure through Mar 2026 stood at $776000.0 (changed N/A YoY), and the FY2025 full-year result was $752000.0, up 67.48% from the prior year.
  • Current Leases for Q1 2026 stood at $776000.0, up from $752000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $776000.0 in Q1 2026 and bottomed at $449000.0 in Q4 2024.
  • The 3-year median for Current Leases is $661000.0 (2025), against an average of $641800.0.
  • Peak annual rise in Current Leases reached 67.48% in 2025, while the deepest fall reached 67.48% in 2025.
  • A 3-year view of Current Leases shows it stood at $449000.0 in 2024, then surged by 67.48% to $752000.0 in 2025, then rose by 3.19% to $776000.0 in 2026.
  • The last three Current Leases figures came in at $776000.0 (Q1 2026), $752000.0 (Q4 2025), and $661000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 12.15 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 6.74 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 9.92 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 4.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 2.11 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 5.60 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 11.33 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 2.11 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Carlsmed 298.68 Mn 201.48 Mn 12.43 Mn 776,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 776,000.00
Dec 31, 2025 752,000.00
Sep 30, 2025 661,000.00
Jun 30, 2025 571,000.00
Dec 31, 2024 449,000.00